262 related articles for article (PubMed ID: 14558960)
21. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance.
Denny L; Kuhn L; Pollack A; Wright TC
Cancer; 2002 Mar; 94(6):1699-707. PubMed ID: 11920531
[TBL] [Abstract][Full Text] [Related]
22. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
23. Should all women with cervical atypia be referred for colposcopy: a HARNET study. Harrisburgh Area Research Network.
Slawson DC; Bennett JH; Simon LJ; Herman JM
J Fam Pract; 1994 Apr; 38(4):387-92. PubMed ID: 8163964
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of visual inspection with acetic acid in detecting high-grade cervical intraepithelial neoplasia in pre- and post-menopausal Thai women with minor cervical cytological abnormalities.
Poomtavorn Y; Suwannarurk K
Asian Pac J Cancer Prev; 2015; 16(6):2327-31. PubMed ID: 25824759
[TBL] [Abstract][Full Text] [Related]
25. HPV testing in primary screening of older women.
Cuzick J; Beverley E; Ho L; Terry G; Sapper H; Mielzynska I; Lorincz A; Chan WK; Krausz T; Soutter P
Br J Cancer; 1999 Oct; 81(3):554-8. PubMed ID: 10507785
[TBL] [Abstract][Full Text] [Related]
26. Agreement between visual inspection with acetic acid and Papanicolaou's smear as screening methods for cervical cancer.
Naz U; Hanif S
J Coll Physicians Surg Pak; 2014 Apr; 24(4):228-31. PubMed ID: 24709232
[TBL] [Abstract][Full Text] [Related]
27. Visual inspection with acetic acid and cytology in the early detection of cervical neoplasia in Kolkata, India.
Basu PS; Sankaranarayanan R; Mandal R; Roy C; Das P; Choudhury D; Bhattacharya D; Chatterjee R; Dutta K; Barik S; Tsu V; Chakrabarti RN; Siddiqi M;
Int J Gynecol Cancer; 2003; 13(5):626-32. PubMed ID: 14675346
[TBL] [Abstract][Full Text] [Related]
28. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
29. Visual inspection with acetic acid as a feasible screening test for cervical neoplasia in Iran.
Ghaemmaghami F; Behtash N; Modares Gilani M; Mousavi A; Marjani M; Moghimi R
Int J Gynecol Cancer; 2004; 14(3):465-9. PubMed ID: 15228419
[TBL] [Abstract][Full Text] [Related]
30. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
31. Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy.
Pretorius RG; Kim RJ; Belinson JL; Elson P; Qiao YL
J Low Genit Tract Dis; 2006 Jan; 10(1):5-9. PubMed ID: 16378026
[TBL] [Abstract][Full Text] [Related]
32. Optimizing the hybrid capture II human papillomavirus test to detect cervical intraepithelial neoplasia.
Howard M; Sellors J; Kaczorowski J
Obstet Gynecol; 2002 Nov; 100(5 Pt 1):972-80. PubMed ID: 12423863
[TBL] [Abstract][Full Text] [Related]
33. A comparison of the reliability of repeat cervical smears and colposcopy in patients with abnormal cervical cytology.
Mayeaux EJ; Harper MB; Abreo F; Pope JB; Phillips GS
J Fam Pract; 1995 Jan; 40(1):57-62. PubMed ID: 7807039
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China.
Zong LJ; Zhang YZ; Yang XS; Jiang J; Cui BX; Qiao YB; Li L; Jiang K; Zhang WJ; Kong BH; Shen K
Asian Pac J Cancer Prev; 2015; 16(5):1907-12. PubMed ID: 25773843
[TBL] [Abstract][Full Text] [Related]
35. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.
Qiao YL; Sellors JW; Eder PS; Bao YP; Lim JM; Zhao FH; Weigl B; Zhang WH; Peck RB; Li L; Chen F; Pan QJ; Lorincz AT
Lancet Oncol; 2008 Oct; 9(10):929-36. PubMed ID: 18805733
[TBL] [Abstract][Full Text] [Related]
36. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
37. Comparing cytology, colposcopy and human papillomavirus cervical intraepithelial lesion screening methods in women with systemic lupus erythematosus.
García-Carrasco M; Mendoza-Pinto C; Méndez-Martínez S; Rodríguez-Reyes A; Munguía-Realpozo P; Taboada-Cole A; Vallejo-Ruiz V; Etchegaray-Morales I; Jiménez-Herrera R; Juárez-Melchor D; Villanueva-López I
Lupus; 2020 Aug; 29(9):1060-1066. PubMed ID: 32501171
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
[No Abstract] [Full Text] [Related]
39. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
[TBL] [Abstract][Full Text] [Related]
40. Screening of cervical neoplasia in HIV-infected women in India.
Joshi S; Sankaranarayanan R; Muwonge R; Kulkarni V; Somanathan T; Divate U
AIDS; 2013 Feb; 27(4):607-15. PubMed ID: 23079814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]